CLINICAL_TRIALS trial_result · 2026-04-23

Clinical Trial Update: A Study in Subjects With Retinitis Pigmentosa [Phase 2]

Phase 2 trial in Retinitis Pigmentosa completed; results have been posted by Aldeyra Therapeutics.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Retinitis Pigmentosa | Phase 2 | Status: COMPLETED | Results posted: 2026-04-23